Five-Year LOE Impact Approaches $200bn

Stelara, Eylea, Vyvanse And Xarelto Among Key Targets For Biosimilars And Generics To 2028

 
• By David Wallace
  
Purple icon reading $200bn
The impact of LOEs for the leading 10 developed markets from 2024 to 2028 is nearing $200bn • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products